The RCMI Program in Health Disparities Research at Meharry Medical College
Project Number3U54MD007586-34S7
Former Number5U54MD007586-34
Contact PI/Project LeaderADUNYAH, SAMUEL EVANS Other PIs
Awardee OrganizationMEHARRY MEDICAL COLLEGE
Description
Abstract Text
Abstract
COVID-19 has created a "state of emergency" for African Americans in the US. Africans Americans with pre-
existing conditions and greater economic difficulties are especially vulnerable in the current pandemic. As of
3/1/2021, three vaccines have received emergency use authorization that protect against severe illness related
to COVID-19. However, recent findings indicate 31% of adults self-reported “wait and see”, of which 16% were
African American. It is a national priority to identify strategies to address vaccine hesitancy and tailoring
communication strategies is a top recommendation. Our preliminary studies suggest that a social marketing
campaign disseminating tailored messages informed by using community-engaged approaches may effectively
increase confidence in COVID-19 vaccines, and ultimately, uptake among African Americans. This project
seeks to test the feasibility and impact of a multi-layered, culturally-appropriate social marketing intervention
targeting COVID-19 vaccine hesitant (VH) African Americans to increase vaccine confidence, uptake, and
completion of multi-dose vaccine series in Nashville/Davidson County, Tennessee. To achieve this goal, we
propose the following specific aims: Aim 1: Engage with key stakeholders to develop a multi-layered,
culturally-appropriate social marketing intervention (CoVax Facts) targeting African Americans who are
COVID-19 VH. Aim 2a: Conduct a pilot study of the intervention and study protocol to demonstrate feasibility
and assess impact on COVID-19 vaccine rates. Aim 2b. To retrospectively explore knowledge, attitudes,
intentions, and implementation outcomes post intervention. This study’s novelty lies in being the first to assess
the feasibility and preliminary efficacy of a multi-layered, theory-based social marketing intervention, which is
deemed culturally-appropriate using tailoring strategies. A multi-disciplinary group of investigators on this
project have expertise in biological concepts (e.g., viruses and vaccines), epidemiology (e.g., COVID-19
surveillance/disparities), vaccine hesitancy, community engagement, health communication, and intervention
development and implementation science. Our team is led by Jennifer C. Erves, PhD, MPH, MAED, MS,
CHES (Meharry Medical College [MMC]), Co-Is Jamaine Davis, PhD (MMC) and Heather Brandt, PhD (St.
Jude), and mentor Maureen Sanderson, PhD (MMC). The research team will leverage their community
partnerships and resources of the Research Centers in Minority Institutions Program in Health Disparities
Research at MMC, Vanderbilt Qualitative Research Core, and St. Jude HPV Cancer Prevention Program to
conduct this research. IMPACT: The knowledge, experience, and data provided by this award will: 1) further
inform research on social-marketing interventions using tailored health communication to reduce COVID-19
health-related disparities, and 2) prepare our team to secure future R01 funding to assess a larger, well-
powered RCT to assess efficacy. This application supports the NIMHD’s mission by seeking to improve
minority health and reduce disparities using community engagement.
Public Health Relevance Statement
Public Health Relevance/Project Narrative
Improving COVID-19 vaccine rates among African Americans who are vaccine hesitant is necessary to
improve the disparities in incidence, mortality, and hospitalization rates in this high-risk group. This proposed
research is innovative because a multi-disciplinary team has been assembled to apply community-engaged
research principles to develop a social marketing intervention disseminating tailored educational messages.
National Institute on Minority Health and Health Disparities
CFDA Code
307
DUNS Number
041438185
UEI
DLTJBDQBGBC9
Project Start Date
30-September-1997
Project End Date
30-June-2022
Budget Start Date
01-April-2021
Budget End Date
30-June-2021
Project Funding Information for 2021
Total Funding
$268,287
Direct Costs
$184,390
Indirect Costs
$83,897
Year
Funding IC
FY Total Cost by IC
2021
National Institute on Minority Health and Health Disparities
$268,287
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U54MD007586-34S7
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54MD007586-34S7
Patents
No Patents information available for 3U54MD007586-34S7
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54MD007586-34S7
Clinical Studies
No Clinical Studies information available for 3U54MD007586-34S7
News and More
Related News Releases
No news release information available for 3U54MD007586-34S7
History
No Historical information available for 3U54MD007586-34S7
Similar Projects
No Similar Projects information available for 3U54MD007586-34S7